- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00260013
Transition Into Primary-care Psychiatry (TIPP)
Transition Into Primary-care Psychiatry (TIPP): A Mental Health Demonstration Project.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The TIPP service will consist, at both the London and Thunder bay sites, of: (i) a mental health care nurse (B.Sc.N.) with at least several years experience as an outpatient mental health service clinician, and (ii) a psychiatrist with a license to practice medicine in the Province of Ontario and sensitivity to the issues of family physicians providing mental health services in the community
The TIPP intervention will involve a service delivery that is a modification of the Consultation Liaison in Primary-care Psychiatry (CLIPP) program
Four elements will act in synthesis and enable collaboration between the primary care and TIPP teams:
(i) Co-location of mental health services staff will involve the psychiatric nurse and psychiatrist visiting the family physicians' office at 1 and 3-month intervals, respectively. During these visits they will review and document the client's progress. This empowers the family physician as clinical manager. Treatment plans will be developed for family physicians that can be easily implemented. The family physician will monitor the client's status between the psychiatric nurse and psychiatrist's visits. At times of greater need, and/or impending crisis, increase in contact to every 14 days, with weekly or more from the family physician, and contacts with all providers adjusted to accommodate client needs. By developing linkages with area mental health services the psychiatric nurse will assist the family physician in co-coordinating access, while minimizing redundant use, to these services.
(ii) The TIPP nurse will select, prepare, and facilitate appropriate clients from the outpatient department for transfer to the family physician. The initial transfer process includes a face-to-face meeting with the client, TIPP nurse and family physician in family physician's office. Warning signs and symptoms of an impending relapse will allow for an opportunity for intervention to prevent or lessen the severity of a relapse. For each client a "relapse signature" strategy will be developed by the TIPP nurse to assist the family physician in detecting clients at high risk of mental illness relapse. Having obtained the client's permission significant caregivers will be routinely involved in the development and implementation of a clinical management plan. Standardized CLIPP based contact sheets\data sheets will promote efficient and effective communication between clinical care providers.
(iii) Client monitoring will be maintained by administrative staff support procedures targeted at ensuring a high level of retention and effective client follow up. The family physician will complete a Clinical Global Impression Scale (CGIS) (severity and change scores) every 3 months in the first year then at each visit for the remainder of the project. The CGIS will not add time to the clinical time with the clients. An administrative member of the project receiving these scales will alert the appropriate clinical providers for clients whose condition is not improving as judged by the family physician.
(iv) Telephone back up for the family physicians' whose clients are involved in the project will be provided by a project psychiatrist and/or psychiatric nurse.
The outcomes of the TIPP intervention clients will be compared to those who receive post outpatient service transfer care-as-usual from their family physician. The clients in this group will obtain any and all services normally available inside or outside their primary care service, including re-referral to specialty mental health care. No additional services will be provided for the care-as-usual group, but no usual services will be limited or withheld. Design features to ensure the interests of the control group are considered include outcomes assessment for both groups at 6, and 12 months, as well as at the projects end point. Should significant clinical concerns be noted by the rater during the assessment a systematic process will allow for the family physician to be notified so as to minimize the risk of compromised care.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Ontario
-
Thunder Bay, Ontario, Canada, P7B 5G4
- St. Joseph's Care Group Lakehead Psychiatric Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- (1) receiving outpatient psychiatric clinic services through the St. Joseph's Care Group Lakehead Psychiatric Hospital in the Community Mental Health Services program, Thunder Bay, Ontario or at the Regional Mental Health Care, Specialized Adult Service, London, Ontario 2) 18-65 years of age; 3) chronic moderate to severe mental illness - all scores below severe or very severe rating on the Threshold Assessment Grid; 4) duration of mental illness of at least 2 years; 5) not regularly receiving psychiatric or mental health care from another family physician, and; 6)capable of understanding the nature of the project and can give consent.
Exclusion Criteria:
Clients will be excluded if at the time of recruitment they:
- have an unstable mental illness;
- had a psychiatric hospitalization admission within the last past 6 months;
- used crisis intervention within the past 6 months (requiring subsequent contact greater than once per week);
- had a history of self-harm over the past 6 months;
- had a history of harm to others over the past 6 months;
- had drug and alcohol problems over the past 6 months that would contribute significantly to clinical destabilization;
- have unmet major psychosocial needs (including homelessness and marked poverty), and;
- are experiencing a serious medical illness that is unstable and that contributes to instability of mental illness.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Quality of Well Being
|
Secondary Outcome Measures
Outcome Measure |
---|
Satisfaction
|
Cost Effectiveness
|
Symptomatology
|
Perceived need for care
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: John M Haggarty, BSc MD FRCPC, St. Joseph's Care Group
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R-04-093
- G03-05687 (Other Grant/Funding Number: Government of Ontario G03-05687)
- 10349E (Other Identifier: University of Western Ontario Research Ethics Board)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorders
-
Kansas State UniversityAugusta University; Dartmouth College; University of CincinnatiEnrolling by invitationMental Disorders, Severe | Mental Illness PersistentUnited States
-
VA Boston Healthcare SystemUS Department of Veterans AffairsCompletedMental Health DisordersUnited States
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada
-
University of ManchesterEuropean Research CouncilRecruitingMental Disorders, SevereUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Active, not recruitingMental Disorders, SevereSpain
-
University of North Carolina, Chapel HillU.S. Department of JusticeCompletedMental Disorders, SevereUnited States
-
Liga Romana pentru Sanatate MintalaPsychiatric Hospital for Chronic Patients Siret, Suceava, RomaniaUnknown
Clinical Trials on program of care delivery
-
Children's Hospital Medical Center, CincinnatiUganda Heart InstituteRecruitingAccelerating Delivery of rheUmatic Heart Disease Preventive iNterventions in Northern Uganda (ADUNU)Rheumatic Heart DiseaseUganda
-
Baylor College of MedicineChildren's National Research InstituteRecruitingType 1 DiabetesUnited States
-
Mind Matters Research LLCCompleted
-
Massachusetts General HospitalNot yet recruitingInsomnia | Cancer Survivorship
-
University of WashingtonAgency for Healthcare Research and Quality (AHRQ)CompletedConstipation | Sinusitis | Allergic Rhinitis | Bronchiolitis | Urticaria | Pharyngitis | Croup | Acute Otitis MediaUnited States
-
Brigham and Women's HospitalCompletedAcute Kidney InjuryUnited States
-
Western University, CanadaCanadian Institutes of Health Research (CIHR); Public Health Agency of Canada...CompletedObesity | OverweightCanada, United States
-
University College, LondonLondon School of Hygiene and Tropical Medicine; Africa Health Research InstituteUnknown
-
Kaiser PermanenteNational Institute on Drug Abuse (NIDA)Active, not recruitingOpioid Use Disorder | Substance Use Disorders | Substance Abuse | Opioid Abuse | Drug Abuse | Drug Use Disorders | Cannabis Abuse | Cannabis-Related Disorder